Literatures

Primary Site >> Biliary tract Cancer

Gene >> MAPK1

1.
Journal:	Hepatology. 1999 Nov;30(5):1128-33.
Title:	Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.
Author:	Park, J\|Tadlock, L\|Gores, G J\|Patel, T
PMID:	10534331

2.
Journal:	Hepatology. 2001 Jan;33(1):43-51.
Title:	Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
Author:	Tadlock, L\|Patel, T
PMID:	11124819

3.
Journal:	Hepatology. 2002 Aug;36(2):363-73.
Title:	Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
Author:	Wu, Tong\|Han, Chang\|Lunz, John G 3rd\|Michalopoulos, George\|Shelhamer, James H\|Demetris, A Jake
PMID:	12143044

4.
Journal:	Gastroenterology. 2002 Apr;122(4):985-93.
Title:	Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.
Author:	Yoon, Jung-Hwan\|Higuchi, Hajime\|Werneburg, Nathan W\|Kaufmann, Scott H\|Gores, Gregory J
PMID:	11910351

5.
Journal:	Gut. 2003 May;52(5):706-12.
Title:	Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.
Author:	Tannapfel, A\|Sommerer, F\|Benicke, M\|Katalinic, A\|Uhlmann, D\|Witzigmann, H\|Hauss, J\|Wittekind, C
PMID:	12692057

6.
Journal:	Hepatology. 2003 May;37(5):1122-9.
Title:	Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma.
Author:	Tanaka, Shinji\|Sugimachi, Keishi\|Kameyama, Toshifumi\|Maehara, Shin-Ichiro\|Shirabe, Ken\|Shimada, Mitsuo\|Wands, Jack R\|Maehara, Yoshihiko
PMID:	12717393

7.
Journal:	Hepatology. 2004 Mar;39(3):732-8.
Title:	Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis.
Author:	Yoon, Jung-Hwan\|Canbay, Ali E\|Werneburg, Nathan W\|Lee, Sum P\|Gores, Gregory J
PMID:	14999691

8.
Journal:	J Clin Invest. 2006 Jul;116(7):1843-52. Epub 2006 Jun 8.
Title:	Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Author:	Xu, Xiaoling\|Kobayashi, Shogo\|Qiao, Wenhui\|Li, Cuiling\|Xiao, Cuiying\|Radaeva, Svetlana\|Stiles, Bangyan\|Wang, Rui-Hong\|Ohara, Nobuya\|Yoshino, Tadashi\|LeRoith, Derek\|Torbenson, Michael S\|Gores, Gregory J\|Wu, Hong\|Gao, Bin\|Deng, Chu-Xia
PMID:	16767220

9.
Journal:	J Cancer Res Clin Oncol. 2006 Dec;132(12):805-10. Epub 2006 Jun 23.
Title:	Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.
Author:	Jinawath, Artit\|Akiyama, Yoshimitsu\|Yuasa, Yasuhito\|Pairojkul, Chawalit
PMID:	16794828

10.
Journal:	Mol Cancer Ther. 2006 Jul;5(7):1895-903.
Title:	Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration.
Author:	Hidalgo, Manuel\|Amador, Maria Luz\|Jimeno, Antonio\|Mezzadra, Heather\|Patel, Pina\|Chan, Audrey\|Nielsen, Matthew E\|Maitra, Anirban\|Altiok, Soner
PMID:	16891476

11.
Journal:	Mol Cell Biochem. 2007 Nov;305(1-2):19-26. Epub 2007 Jun 6.
Title:	Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling.
Author:	Zhang, Li\|Jiang, Li\|Sun, Qiuyan\|Peng, Tao\|Lou, Kexin\|Liu, Ningbo\|Leng, Jing
PMID:	17551669

12.
Journal:	Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44.
Title:	Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma.
Author:	Ailawadhi, Sikander\|Nagase, Hiroki\|Khoury, Thaer\|Yu, Jihnhee\|Tan, Dongfeng\|Black, Jennifer\|Brattain, Michael\|Javle, Milind
PMID:	17708250

13.
Journal:	World J Gastroenterol. 2007 Dec 28;13(48):6470-7.
Title:	AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma.
Author:	Schmitz, K J\|Lang, H\|Wohlschlaeger, J\|Sotiropoulos, G C\|Reis, H\|Schmid, K W\|Baba, H A
PMID:	18161916

14.
Journal:	Oncol Rep. 2008 Oct;20(4):863-72.
Title:	The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.
Author:	Matsumoto, Kazuya\|Nagahara, Takakazu\|Okano, Jun-Ichi\|Murawaki, Yoshikazu
PMID:	18813828

15.
Journal:	Mol Cancer Res. 2009 Oct;7(10):1704-13.
Title:	H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
Author:	Francis, Heather\|Onori, Paolo\|Gaudio, Eugenio\|Franchitto, Antonio\|DeMorrow, Sharon\|Venter, Julie\|Kopriva, Shelley\|Carpino, Guido\|Mancinelli, Romina\|White, Mellanie\|Meng, Fanyin\|Vetuschi, Antonella\|Sferra, Roberta\|Alpini, Gianfranco
PMID:	19825989

16.
Journal:	J Exp Clin Cancer Res. 2009 May 18;28:65.
Title:	Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
Author:	Li, Qinglong\|Yang, Zhulin
PMID:	19445727

17.
Journal:	Dig Dis Sci. 2010 Oct;55(10):2844-52.
Title:	The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
Author:	Duan, Shi-Gang\|Cheng, Long\|Li, Da-Jiang\|Zhu, Jin\|Xiong, Yan\|Li, Xiao-Wu\|Wang, Shu-Guang
PMID:	20101459

18.
Journal:	World J Gastroenterol. 2010 Feb 14;16(6):713-22.
Title:	Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Author:	Menakongka, Apaporn\|Suthiphongchai, Tuangporn
PMID:	20135719

19.
Journal:	Hepatogastroenterology. 2010 May-Jun;57(99-100):426-9.
Title:	Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
Author:	Qun, Wang\|Tao, Yin
PMID:	20698202

20.
Journal:	J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):147-53.
Title:	Protease-activated receptor-2 regulates cyclooxygenase-2 expression in human bile duct cancer via the pathways of mitogen-activated protein kinases and nuclear factor kappa B.
Author:	Eguchi, Hidetoshi\|Iwaki, Kentaro\|Shibata, Kohei\|Ogawa, Tadashi\|Ohta, Masayuki\|Kitano, Seigo
PMID:	20740367

21.
Journal:	J Gastroenterol. 2011 May;46(5):664-75.
Title:	Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
Author:	Namwat, N\|Puetkasichonpasutha, J\|Loilome, W\|Yongvanit, P\|Techasen, A\|Puapairoj, A\|Sripa, B\|Tassaneeyakul, W\|Khuntikeo, N\|Wongkham, S
PMID:	21076843

22.
Journal:	Biochem Biophys Res Commun. 2011 Feb 18;405(3):333-7.
Title:	Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2.
Author:	Yoon, Hyunho\|Min, Jeong-Ki\|Lee, Jung Whoi\|Kim, Dae-Ghon\|Hong, Hyo Jeong
PMID:	21130731

23.
Journal:	Invest New Drugs. 2012 Aug;30(4):1646-51.
Title:	SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
Author:	El-Khoueiry, Anthony B\|Rankin, Cathryn J\|Ben-Josef, Edgar\|Lenz, Heinz-Josef\|Gold, Philip J\|Hamilton, R Darryl\|Govindarajan, Rangaswamy\|Eng, Cathy\|Blanke, Charles D
PMID:	21748296

24.
Journal:	Hepatology. 2012 Dec;56(6):2268-76.
Title:	A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.
Author:	Liu, Wangta\|Chen, Jim-Ray\|Hsu, Chih-Hao\|Li, Yen-Hsing\|Chen, Yi-Meng\|Lin, Chien-Yuan\|Huang, Shin-Jie\|Chang, Zen-Kuei\|Chen, Yen-Chun\|Lin, Chi-Hsueh\|Gong, Hong-Yi\|Lin, Ching-Chun\|Kawakami, Koichi\|Wu, Jen-Leih
PMID:	22729936

25.
Journal:	Anticancer Res. 2012 Dec;32(12):5251-62.
Title:	Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells.
Author:	Nakajima, Yoshimi\|Takagi, Hitoshi\|Kakizaki, Satoru\|Horiguchi, Norio\|Sato, Ken\|Sunaga, Noriaki\|Mori, Masatomo
PMID:	23225424

26.
Journal:	ISRN Hepatol. 2013 Nov 17;2013:601071.
Title:	Protective Effects of Guava Pulp on Cholestatic Liver Injury.
Author:	Peng, Jian\|Yue, Chunyan\|Qiu, Kai\|Chen, Jie\|Aller, Maria-Angeles\|Ko, Kwang Suk\|Yang, Heping
PMID:	27335829

27.
Journal:	Oncol Lett. 2013 Nov;6(5):1439-1446.
Title:	CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2.
Author:	Leelawat, Kawin\|Keeratichamroen, Siriporn\|Leelawat, Surang\|Tohtong, Rutaiwan
PMID:	24179538

28.
Journal:	Hepatology. 2013 Jun;57(6):2248-60.
Title:	Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.
Author:	Cui, Xiang-Dan\|Lee, Mi-Jin\|Kim, Jong-Hyun\|Hao, Pei-Pei\|Liu, Lan\|Yu, Goung-Ran\|Kim, Dae-Ghon
PMID:	23315987

29.
Journal:	Clin Cancer Res. 2013 Jan 1;19(1):118-27.
Title:	Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancer.
Author:	Xu, Junyao\|Knox, Jennifer J\|Ibrahimov, Emin\|Chen, Eric\|Serra, Stefano\|Tsao, Ming\|Cao, Pinjiang\|Vines, Douglass\|Green, David E\|Metran-Nascente, Cristiane\|McNamara, Mairead G\|Hedley, David W
PMID:	23091117

30.
Journal:	Int J Oncol. 2013 Feb;42(2):690-8.
Title:	Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
Author:	Yang, Wei\|Wang, Xiaoyuan\|Zheng, Wei\|Li, Kedong\|Liu, Haofeng\|Sun, Yueming
PMID:	23254774

31.
Journal:	Biochimie. 2014 Jun;101:183-91.
Title:	Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-kappaB pathway.
Author:	Li, Wenjiao\|Li, Ming\|Su, Xinhui\|Qin, Liping\|Miao, Mengmeng\|Yu, Chundong\|Shen, Yuemao\|Luo, Qi\|Chen, Qiang
PMID:	24486723

32.
Journal:	Cancer Biol Ther. 2014 Jun 1;15(6):806-14.
Title:	MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.
Author:	Wu, Xiang-Song\|Wang, Xu-An\|Wu, Wen-Guang\|Hu, Yun-Ping\|Li, Mao-Lan\|Ding, Qian\|Weng, Hao\|Shu, Yi-Jun\|Liu, Tian-Yu\|Jiang, Lin\|Cao, Yang\|Bao, Run-Fa\|Mu, Jia-Sheng\|Tan, Zhu-Jun\|Tao, Feng\|Liu, Ying-Bin
PMID:	24658096

33.
Journal:	Hepatology. 2014 Sep;60(3):908-18.
Title:	Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
Author:	Liu, Runping\|Zhao, Renping\|Zhou, Xiqiao\|Liang, Xiuyin\|Campbell, Deanna J W\|Zhang, Xiaoxuan\|Zhang, Luyong\|Shi, Ruihua\|Wang, Guangji\|Pandak, William M\|Sirica, Alphonse E\|Hylemon, Phillip B\|Zhou, Huiping
PMID:	24700501

34.
Journal:	Tumour Biol. 2015 Mar;36(3):1781-9.
Title:	Up-regulation of 14-3-3zeta expression in intrahepatic cholangiocarcinoma and its clinical implications.
Author:	Zhang, Chi\|Liu, Li-Xin\|Dong, Zhao-Ru\|Shi, Guo-Ming\|Cai, Jia-Bin\|Zhang, Peng-Fei\|Ke, Ai-Wu\|Yu, Jing-Xian\|Zhou, Jian\|Fan, Jia
PMID:	25391422

35.
Journal:	Tumour Biol. 2015 Jul;36(7):5171-7.
Title:	Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer.
Author:	Zong, Huajie\|Yin, Baobing\|Zhou, Huading\|Cai, Duan\|Ma, Baojin\|Xiang, Yang
PMID:	25663464

36.
Journal:	Int J Oncol. 2015;46(6):2317-26.
Title:	Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway.
Author:	Amonyingcharoen, Sumet\|Suriyo, Tawit\|Thiantanawat, Apinya\|Watcharasit, Piyajit\|Satayavivad, Jutamaad
PMID:	25815516

37.
Journal:	BMC Cancer. 2015 Nov 16;15:903.
Title:	Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44nu is an indicator for recurrence in advanced cancer.
Author:	Wu, Cheng-Lin\|Chao, Ying-Jui\|Yang, Ta-Ming\|Chen, Yi-Ling\|Chang, Kung-Chao\|Hsu, Hui-Ping\|Shan, Yan-Shen\|Lai, Ming-Derg
PMID:	26572077

38.
Journal:	BMC Cancer. 2016 Mar 19;16:240.
Title:	TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
Author:	Hong, HaiJie\|Jiang, Lei\|Lin, YanFei\|He, CaiLong\|Zhu, GuangWei\|Du, Qiang\|Wang, XiaoQian\|She, FeiFei\|Chen, YanLing
PMID:	26992854

39.
Journal:	Oncotarget. 2016 Nov 8;7(45):72833-72844.
Title:	Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
Author:	Shen, Sheng\|Liu, Han\|Wang, Yueqi\|Wang, Jiwen\|Ni, Xiaolin\|Ai, Zhilong\|Pan, Hongtao\|Liu, Houbao\|Shao, Yebo
PMID:	27637083

40.
Journal:	PLoS One. 2016 Sep 14;11(9):e0162594.
Title:	Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation.
Author:	Hall, Terence G\|Yu, Yi\|Eathiraj, Sudharshan\|Wang, Yunxia\|Savage, Ronald E\|Lapierre, Jean-Marc\|Schwartz, Brian\|Abbadessa, Giovanni
PMID:	27627808

41.
Journal:	J Exp Clin Cancer Res. 2016 Apr 16;35:68.
Title:	Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Author:	Cao, Yang\|Liang, Haibin\|Zhang, Fei\|Luan, Zhou\|Zhao, Shuai\|Wang, Xu-An\|Liu, Shibo\|Bao, Runfa\|Shu, Yijun\|Ma, Qiang\|Zhu, Jian\|Liu, Yingbin
PMID:	27084680

42.
Journal:	Mol Med Rep. 2016 May;13(5):4461-8.
Title:	Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis.
Author:	Jia, Jianguang\|Qin, Yiyu\|Zhang, Ligong\|Guo, Chenxu\|Wang, Yaguo\|Yue, Xicheng\|Qian, Jun
PMID:	27035431

43.
Journal:	World J Gastroenterol. 2016 Feb 14;22(6):2071-80.
Title:	Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
Author:	Ding, Ning\|Che, Li\|Li, Xiao-Lei\|Liu, Yan\|Jiang, Li-Jie\|Fan, Biao\|Tao, Jun-Yan\|Chen, Xin\|Ji, Jia-Fu
PMID:	26877611

44.
Journal:	Tumour Biol. 2016 Jul;37(7):9451-63.
Title:	YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Author:	Thongsom, Sunisa\|Chaocharoen, Wethaka\|Silsirivanit, Atit\|Wongkham, Sopit\|Sripa, Banchob\|Choe, Han\|Suginta, Wipa\|Talabnin, Chutima
PMID:	26781979

45.
Journal:	Gut Liver. 2016 Mar;10(2):310-7.
Title:	Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells.
Author:	Lee, Jin\|Hong, Eun Mi\|Jang, Ju Ah\|Park, Se Woo\|Koh, Dong Hee\|Choi, Min Ho\|Jang, Hyun Joo\|Kae, Sea Hyub
PMID:	26470769

46.
Journal:	Gut. 2016 Mar;65(3):487-501.
Title:	TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
Author:	Reich, Maria\|Deutschmann, Kathleen\|Sommerfeld, Annika\|Klindt, Caroline\|Kluge, Stefanie\|Kubitz, Ralf\|Ullmer, Christoph\|Knoefel, Wolfram T\|Herebian, Diran\|Mayatepek, Ertan\|Haussinger, Dieter\|Keitel, Verena
PMID:	26420419

47.
Journal:	Oncotarget. 2017 Feb 28;8(9):15775-15788.
Title:	Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.
Author:	Wang, Yueqi\|Gao, Zhihui\|Zhang, Dexiang\|Bo, Xiaobo\|Wang, Yaojie\|Wang, Jiwen\|Shen, Sheng\|Liu, Han\|Suo, Tao\|Pan, Hongtao\|Ai, Zhilong\|Liu, Houbao
PMID:	28178656

48.
Journal:	Pathol Res Pract. 2017 May;213(5):476-482.
Title:	The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Author:	Buchegger, Kurt\|Silva, Ramon\|Lopez, Jaime\|Ili, Carmen\|Araya, Juan Carlos\|Leal, Pamela\|Brebi, Priscilla\|Riquelme, Ismael\|Roa, Juan Carlos
PMID:	28285962

49.
Journal:	Cancer Lett. 2017 Sep 10;403:66-73.
Title:	Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer.
Author:	Takasawa, Kumi\|Takasawa, Akira\|Osanai, Makoto\|Aoyama, Tomoyuki\|Ono, Yusuke\|Kono, Tsuyoshi\|Hirohashi, Yoshihiko\|Murata, Masaki\|Sawada, Norimasa
PMID:	28624624

50.
Journal:	J Transl Med. 2017 Nov 25;15(1):238.
Title:	Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Author:	Tang, Jing\|Liao, Yan\|He, Shuying\|Shi, Jie\|Peng, Liang\|Xu, Xiaoping\|Xie, Fang\|Diao, Na\|Huang, Jinlan\|Xie, Qian\|Lin, Chuang\|Luo, Xiaoying\|Liao, Kaili\|Ma, Juanjuan\|Li, Jingyi\|Zhou, Daichao\|Li, Zhijun\|Xu, Jun\|Zhong, Chao\|Wang, Guozhen\|Bai, Lan
PMID:	29178939

51.
Journal:	Cytotechnology. 2018 Feb;70(1):439-448.
Title:	Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.
Author:	Bi, Tingting\|Zhu, Ao\|Yang, Xufeng\|Qiao, Huiying\|Tang, Jinmei\|Liu, Yan\|Lv, Rong
PMID:	29110119

52.
Journal:	Cell Death Dis. 2018 Jan 18;9(2):31.
Title:	Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.
Author:	Dong, Mingjie\|Liu, Xianqiong\|Evert, Katja\|Utpatel, Kirsten\|Peters, Michele\|Zhang, Shanshan\|Xu, Zhong\|Che, Li\|Cigliano, Antonio\|Ribback, Silvia\|Dombrowski, Frank\|Cossu, Antonio\|Gordan, John\|Calvisi, Diego F\|Evert, Matthias\|Liu, Yan\|Chen, Xin
PMID:	29348467

53.
Journal:	Cell Death Dis. 2018 Feb 7;9(2):179.
Title:	Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of beta-Catenin.
Author:	Zheng, Yan\|Zhou, Chuang\|Yu, Xin-Xin\|Wu, Chao\|Jia, Hu-Liang\|Gao, Xiao-Mei\|Yang, Ji-Meng\|Wang, Chao-Qun\|Luo, Qin\|Zhu, Ying\|Zhang, Yu\|Wei, Jin-Wang\|Sheng, Yuan-Yuan\|Dong, Qiong-Zhu\|Qin, Lun-Xiu
PMID:	29415992

54.
Journal:	Biochem Biophys Res Commun. 2018 May 15;499(3):433-440.
Title:	Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation.
Author:	Chen, Jian\|Song, Wenfeng\|Du, Yehui\|Li, Zequn\|Xuan, Zefeng\|Zhao, Long\|Chen, Jun\|Zhao, Yongchao\|Tuo, Biguang\|Zheng, Shusen\|Song, Penghong
PMID:	29574153

55.
Journal:	Int J Mol Sci. 2018 Oct 12;19(10). pii: ijms19103141.
Title:	MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner.
Author:	Miao, Wenyu\|Sakai, Katsuya\|Imamura, Ryu\|Ito, Kenichiro\|Suga, Hiroaki\|Sakuma, Tetsushi\|Yamamoto, Takashi\|Matsumoto, Kunio
PMID:	30322054